Medscape

Does Immunosuppression Prevent Pulmonary Arterial Hypertension in Systemic Sclerosis?

MANCHESTER, England — Use of immunosuppressive drugs within 5 years of the onset of systemic sclerosis (SSc) did not lower patients’ risk for developing pulmonary arterial hypertension (PAH) but was ...
Healio

All patients with systemic sclerosis require screening for interstitial lung disease, PAH

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — All patients with systemic sclerosis should be screened for pulmonary arterial hypertension and ...
Healio

Cytokine profiles distinguish risk for pulmonary arterial hypertension in systemic sclerosis

Please provide your email address to receive an email when new articles are posted on . Cytokine profiles can distinguish patients with systemic sclerosis who are at high risk for, or have, pulmonary ...
Medical Xpress

Experts update recommendations for modern approach for systemic sclerosis

Systemic sclerosis (SSc) is a rare connective tissue disorder, with both autoimmune and vascular features. The main hallmark is tissue and vascular fibrosis that can result in clinical heterogeneity ...